Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles Eye Drops in Dry Eye Disease
NCT07623382Phase 1Recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Mar 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in dry eye disease (DED), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoints: Total Corneal Fluorescein Staining at 4 weeks and Tear Film Break-up Time at 4 weeks. Started Mar 2026; status: recruiting.
02
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07623382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07623382.